<DOC>
	<DOC>NCT00989209</DOC>
	<brief_summary>Objective: Quantify the benefits of myofunctional therapy associated to botulinum toxin injection in patients with long standing facial unilateral palsy.</brief_summary>
	<brief_title>Myofunctional Therapy in Facial Palsy</brief_title>
	<detailed_description>Twenty-five patients with long standing facial palsy were studied; all had been previously treated for facial reanimation. Patients were randomly divided in two groups; Group A did the myofunctional therapy sessions with the speech therapist before the botulinum toxin injection, while the participants of Group B did the myofunctional therapy after it.</detailed_description>
	<mesh_term>Facies</mesh_term>
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Facial Paralysis</mesh_term>
	<mesh_term>Bell Palsy</mesh_term>
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>facial paralysis with more than 2 years elapsed since the onset of symptoms surgically treated for reanimation at least 12 months before static and/or dynamic facial asymmetry causing aesthetic concern spastic paralysis serious systemic or neuromuscular diseases cognition impairment pregnant women</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>62 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>facial paralysis</keyword>
	<keyword>asymmetry</keyword>
	<keyword>myofunctional therapy</keyword>
	<keyword>botulinum toxin</keyword>
	<keyword>facial evaluation</keyword>
</DOC>